Kalvista Pharmaceuticals, Inc. (KALV) — DEF 14A Filings
All DEF 14A filings from Kalvista Pharmaceuticals, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
KalVista Pharma Files Definitive Proxy Statement
— Aug 22, 2024 Risk: low
KalVista Pharmaceuticals, Inc. filed its definitive proxy statement on August 22, 2024, for its annual meeting of stockholders on October 3, 2024. The filing de
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX